Conatus Pharmaceuticals Appoints David T. Hagerty as Executive VP, Clinical Development
October 01, 2014 at 16:01 PM EDT
Conatus Pharmaceuticals Inc. (Nasdaq: CNAT), a biotechnology company focused on the development and commercialization of novel medicines ...
